Cyclerion Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Cyclerion Therapeutics has filed a definitive proxy statement with the SEC.
NASDAQ
Cyclerion Therapeutics will hold its annual shareholder meeting virtually on June 16, 2025, to vote on director elections, auditor ratification, executive compensation, and other proposals.
NASDAQ
Cyclerion Therapeutics has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
Cyclerion Therapeutics announces its Annual Meeting of Shareholders to be held virtually on June 14, 2024, to vote on director elections, auditor ratification, and an adjournment proposal.